Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples